BioCentury
ARTICLE | Clinical News

Aware HIV-1/2 OMT regulatory update

July 16, 2007 7:00 AM UTC

CBMC received Indian marketing approval for its Aware HIV-1/2 OMT, an in vitro point-of-care immunoassay to detect HIV-1 and HIV-2 antibodies in oral fluid samples. ...